Guanze Medical Information Industry (Holding) Co., Ltd.
Guanze Medical Information Industry (Holding) Co., Ltd., commonly referred to as Guanze Group, is a prominent player in the healthcare sector, headquartered in China. Established in 2001, the company has made significant strides in medical information services, focusing on areas such as healthcare data management, clinical research, and medical consulting. With a strong operational presence across various regions in Asia, Guanze Group is renowned for its innovative solutions that enhance healthcare delivery and patient outcomes. The company’s core offerings include advanced medical information systems and comprehensive data analytics, setting it apart in a competitive market. Recognised for its commitment to quality and excellence, Guanze Group has achieved notable milestones, solidifying its position as a trusted partner in the medical information industry.
DitchCarbon Score
How does Guanze Medical Information Industry (Holding) Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Guanze Medical Information Industry (Holding) Co., Ltd.'s score of 17 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Guanze Medical Information Industry (Holding) Co., Ltd.'s reported carbon emissions
In 2022, Guanze Medical Information Industry (Holding) Co., Ltd. reported total carbon emissions of approximately 89,380 kg CO2e, with Scope 1 emissions accounting for about 76,450 kg CO2e and Scope 2 emissions at approximately 12,930 kg CO2e. This marked an increase from 2021, when total emissions were about 77,070 kg CO2e, comprising approximately 65,110 kg CO2e from Scope 1 and about 11,960 kg CO2e from Scope 2. Despite the increase in emissions, Guanze Medical has not disclosed any specific reduction targets or initiatives aimed at mitigating their carbon footprint. The company has not provided data on Scope 3 emissions, which typically encompass indirect emissions from the supply chain and product use. As the industry increasingly focuses on sustainability, Guanze Medical's lack of defined climate commitments may position them at a disadvantage compared to competitors actively pursuing carbon reduction strategies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 65,110 | 00,000 |
| Scope 2 | 11,960 | 00,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Guanze Medical Information Industry (Holding) Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
